AI-generated summary
The authors compared low-level laser therapy alone with low-level laser therapy combined with the drug aceclofenac in 40 patients with myofascial pain dysfunction syndrome, using 940 nm laser over 12 sessions. The authors report that both groups showed reduced pain and improved mouth opening, with faster improvement in the combination group.
- Participants
- 40
- Who or what was studied
- Patients with myofascial pain dysfunction syndrome (temporomandibular disorder), randomly divided into two groups
- Wavelengths
- 940 nm
- Limits stated in the abstract
- The abstract does not describe the study's follow-up beyond two months or the blinding and control arrangements, so the certainty of the findings is unclear.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on ovid.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 940 nm
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.